Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 5
|
pp. 4641–4659
Effects of the probiotic formulation SLAB51 in
in vitro
and
in vivo
Parkinson’s disease models
Back to article
Figure 9
(9 of 14)
−
100%
+
Figure 9.
Immunofluorescence for DAT in mice Substantia nigra.
Images were taken at confocal microscope at 20x magnification.
Figure 9 — Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models | Aging
